Back

Silent threats and strategic solutions: surgical revascularization in diffuse cardiac allograft vasculopathy

10 May 2026 (14:30 - 14:41)
Organised by: Logo
Congress Presentation Part of: Balancing the scales after transplant: rejection, infection, and CAV Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Gulzhan Myrzakhmetova

University Medical Centre, Astana (Kazakhstan)

3 More presentations in this session

Presentation thumbnail
Acute rejection in a heart transplant recipient with hiv seroconversion during the waitlist period and active tuberculosis: a multidisciplinary challenge
Doctor D. Ortega Gomez (Bogota, CO)
Slides Video
Presentation thumbnail
Enteral immunoglobulin therapy for chronic norovirus in a heart transplant recipient
Doctor U. Kharad (London, CA) Doctor A. Haddad (London, CA)
Slides Video
Presentation thumbnail
Biopsy discordant rejection presenting with right ventricular-predominant cardiogenic shock in a stable orthotopic heart transplant recipient
Doctor S. Islam (New York City, US)
Slides Video

Access the full session

Session thumbnail
Balancing the scales after transplant: rejection, infection, and CAV
Video

The Event

Event poster

Heart Failure 2026

10 May 2026 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Case series - Two cases of cardiac allograft vasculopathy (CAV) in young adults followed for approximately 10 years after heart transplantation
thumbnail
Congress Presentation
Modern post-transplant surveillance: acute rejection and cardiac allograft vasculopathy
thumbnail
Congress Presentation
Recanalization of total LAD occlusion with immunosuppression in a case of cardiac allograft vasculopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources